Milestone
Oct 2023
FDA clears the Sparrow Ascent
DP
Oct 13, 2023
Second generation wearable neurostimulation platform cleared for opioid withdrawal management. Reducing COGS by 75% over gen 1.
Second generation wearable neurostimulation platform cleared for opioid withdrawal management. Reducing COGS by 75% over gen 1.